Related references
Note: Only part of the references are listed.Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation Across BMI Categories: A Systematic Review and Meta-Analysis
Yue Zhou et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2020)
Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry
Giuseppe Boriani et al.
EUROPACE (2019)
Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data
Margarita Kushnir et al.
LANCET HAEMATOLOGY (2019)
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight Insights From the ARISTOTLE Trial
Stefan H. Hohnloser et al.
CIRCULATION (2019)
Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial
Giuseppe Boriani et al.
EUROPEAN HEART JOURNAL (2019)
Atrial fibrillation prevention: an appraisal of current evidence
Giuseppe Boriani et al.
HEART (2018)
Impact of body mass index on mortality and hospitalisation of patients with atrial fibrillation
Jocasta Ball et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING (2018)
Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry
Giuseppe Boriani et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2018)
An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases
Andrew Elagizi et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2018)
Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update
Marie-Eve Piche et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2018)
Obesity and Cardiac Remodeling in Adults: Mechanisms and Clinical Implications
Martin A. Alpert et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2018)
Healthy Weight and Obesity Prevention JACC Health Promotion Series
Carl J. Lavie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies
Dagfinn Aune et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2017)
Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis Effects of Weight Loss and Exercise
Carl J. Lavie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials
Marco Proietti et al.
STROKE (2017)
Stroke prevention in atrial fibrillation: Past, present and future Comparing the guidelines and practical decision-making
Gregory Y. H. Lip et al.
THROMBOSIS AND HAEMOSTASIS (2017)
The molecular mechanisms of obesity paradox
Alexios S. Antonopoulos et al.
CARDIOVASCULAR RESEARCH (2017)
The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight-a systematic literature review
Raffaele De Caterina et al.
CLINICAL RESEARCH IN CARDIOLOGY (2017)
Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation Trial)
Somasekhara R. Balla et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
The role of obesity in atrial fibrillation
Chrishan Joseph Nalliah et al.
EUROPEAN HEART JOURNAL (2016)
Body Mass Index and Adverse Outcomes in Elderly Patients With Atrial Fibrillation The AMADEUS Trial
Keitaro Senoo et al.
STROKE (2016)
Relation of Nonvalvular Atrial Fibrillati to Body Mass Index (from the SPORTIF Trials)
Marco Proietti et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
Niniejszy dokument uzyskal poparcie European Stroke Organisation (ESO)
Paulus Kirchhof et al.
KARDIOLOGIA POLSKA (2016)
Association of Smoking, Alcohol, and Obesity with Cardiovascular Death and Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study and Cardiovascular Health Study (CHS)
Younghoon Kwon et al.
PLOS ONE (2016)
Relation of Body Mass Index With Adverse Outcomes Among Patients With Atrial Fibrillation: A Meta-Analysis and Systematic Review
Wengen Zhu et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Pericardial fat and atrial fibrillation: Epidemiology, mechanisms and interventions
Mohamed Al-Rawahi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity
Rajiv Mahajan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort A Long-Term Follow-Up Study (LEGACY)
Rajeev K. Pathak et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Healthy obese versus unhealthy lean: the obesity paradox
Carl J. Lavie et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Effects of Body Mass Index on Risks for Ischemic Stroke, Thromboembolism, and Mortality in Chinese Atrial Fibrillation Patients: A Single-Center Experience
Hai-Jun Wang et al.
PLOS ONE (2015)
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society
Michael D. Jensen et al.
CIRCULATION (2014)
Overweight is associated with improved survival and outcomes in patients with atrial fibrillation
Juan Wang et al.
CLINICAL RESEARCH IN CARDIOLOGY (2014)
Obesity and Cardiovascular Diseases
Carl J. Lavie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Body Mass Index and Adverse Events in Patients with Incident Atrial Fibrillation
Thure Filskov Overvad et al.
AMERICAN JOURNAL OF MEDICINE (2013)
Presence of Apolipoprotein C-III Defines a High Density Lipoprotein Subtype that is not Inversely Associated with Incident Coronary Events
Majken K. Jensen et al.
CIRCULATION (2013)
Absolute and Attributable Risks of Atrial Fibrillation in Relation to Optimal and Borderline Risk Factors The Atherosclerosis Risk in Communities (ARIC) Study
Rachel R. Huxley et al.
CIRCULATION (2011)
Obesity and Outcomes Among Patients With Established Atrial Fibrillation
Afrooz Ardestani et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Influence of Obesity on Outcomes in Atrial Fibrillation: Yet Another Obesity Paradox
Apurva O. Badheka et al.
AMERICAN JOURNAL OF MEDICINE (2010)
Body-Mass Index and Mortality among 1.46 Million White Adults.
Amy Berrington de Gonzalez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss
Carl J. Lavie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Atrial fibrillation and obesity - results of a meta-analysis
Nikolas Wanahita et al.
AMERICAN HEART JOURNAL (2008)
Obesity and the risk of new-onset atrial fibrillation
TJ Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Share Paper
